| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 19,155 | 12,318 | 12,308 | 16,440 | | Cost of Revenue | 10,477 | 7,805 | 8,043 | 10,630 | | | Gross Profit | 8,678 | 4,513 | 4,265 | 5,810 | | | Operating Expenses | | Research Development | 6,840 | 7,385 | 8,030 | 8,657 | | Selling General and Administrative | 5,551 | 5,394 | 5,709 | 6,411 | | Non Recurring |
-
|
-
|
-
| 10,498 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,713) | (8,266) | (9,474) | (19,756) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 122 | 228 | 430 | 831 | | Earnings Before Interest And Taxes | (3,591) | (8,038) | (9,044) | (18,925) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,591) | (8,038) | (9,044) | (18,925) | | Income Tax Expense | (1,799) | (3,551) | (3,271) | (6,307) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,792) | (4,487) | (5,773) | (12,618) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,792) | (4,487) | (5,773) | (12,618) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,792) | ($4,487) | ($5,773) | ($12,618) |
|
0.51% Nasdaq 
0.11 (0.93%) 
Income Statement
